Veteran Tingue CFO Retires; Successor Takes Charge

Posted July 11, 2024 at 4:36 pm




Tingue’s long-time CFO John Hurst recently announced his retirement, effective June 1; his successor, Arnald Capriles, who joined Tingue last November, now has succeeded Hurst as the supplier partner company’s new CFO.

“As John embarks on a well-deserved retirement, a new chapter unfolds for our team,” said David Tingue, the company’s CEO, in a news release. “I’m grateful for the many contributions John has provided us over the last 32 years. And I’m excited for Arnald’s fresh perspective and energy he brings to Team Tingue. I look forward to Arnald building on the strong foundation that John established and achieving new milestones for the company.”

Capriles brings more than 20 years’ experience in finance and business in multinational, public and privately held companies to Tingue. He served most recently as CFO of Exubrion Therapeutics, an animal health startup, backed by private-equity funding. Before that he served as head of finance with Boehringer Ingelheim, the world largest family-owned Animal Health Business. Capriles, a native of Caracas, Venezuela, received an MBA from Boston University and an undergraduate business degree from the Universidad Metropolitana in Caracas. He’s lived and worked in four countries and is now leading a transition of the company’s headquarters offices to the north side of Atlanta. This move will place the office in close proximity to Tingue’s main operating locations in Peachtree City, GA; and Greensboro, NC.

As for Hurst, he’s now concluded a 32-year tenure with Tingue, during which he oversaw the financial team and negotiated deals, while supervising budgetary planning, information technology and data analysis. He’ll be remembered for his positive, supportive spirit and his steadfast loyalty to Tingue, the release said. In recognition of his retirement and many contributions to Tingue, the company named a conference room in its Peachtree City facility in his honor. Click here for more information.

 

124